Landscape of NAT2 polymorphisms among breast cancer

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Tengfei Wang, Hany E Marei

Abstract

The prevalence of phenotypes of Arylamine N-acetyltransferase-2(NAT2) gene (i.e. fast, intermediate and slow acetylators) among ethnic groups, as well as the association studies regarding NAT2 polymorphisms and risk of breast cancer produced inconsistent results. This meta-analysis aimed to clarify whether the selected NAT2 phenotypes have an effect on the susceptibility to breast cancer. After aggregating the frequencies of fast, intermediate and slow phenotypes of NAT2 in breast cancer subjects, the odds ratio and relevant 95% confidence intervals were examined using combined data from all published 36 articles. Overall, our results did not produce statistical significance for the proposed association, suggesting that there is no association between the selected phenotypes of NAT2 polymorphisms and breast cancer. In subgroup analyses, it was revealed that, as compared with the fast phenotype, intermediate acetylator is protective of the vulnerable White population to breast cancer. In addition, an obvious ethnic/geographic difference was found in the prevalence of fast, intermediate and slow acetylators among world-wide populations. Although ethnic and geographic differences in NAT2 polymorphisms were present, this was not as...Continue Reading

References

Nov 13, 1996·JAMA : the Journal of the American Medical Association·C B AmbrosoneP G Shields
Mar 20, 1998·International Journal of Cancer. Journal International Du Cancer·C B AmbrosoneP G Shields
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·D M GertigD J Hunter
Aug 10, 2000·American Journal of Epidemiology·A MorabiaM A Morris
Apr 6, 2001·International Journal of Cancer. Journal International Du Cancer·M KrajinovicD Sinnett
Apr 6, 2002·Mutation Research·Fang Yang WuHsien Wen Kuo
Jul 1, 2004·Cancer Detection and Prevention·Anthony J AlbergDouglas A Bell
Dec 21, 2004·International Journal of Cancer. Journal International Du Cancer·Pia SillanpääKatja Mitrunen
Mar 17, 2006·Breast Cancer Research and Treatment·Lisa GallicchioKathy J Helzlsouer
Apr 15, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Paul D Terry, Michael Goodman
May 23, 2006·The Breast : Official Journal of the European Society of Mastology·Tsai-Wang ChangWenya Huang
May 25, 2006·International Journal of Cancer. Journal International Du Cancer·Jolanta LissowskaMontserrat García-Closas
Dec 20, 2007·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Rikke EgebergAnne Tjønneland
Jan 12, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Christine B AmbrosoneJenny Chang-Claude
Aug 6, 2008·Current Drug Metabolism·José A G Agúndez
Aug 21, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kathy B BaumgartnerDavid W Hein
Dec 10, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Sylvia RabsteinUNKNOWN GENICA Network
Feb 25, 2010·Breast Cancer Research and Treatment·Jian ZhangXi-Chun Hu
Mar 4, 2010·Cancer Epidemiology·Michael S C ConlonAllan Donner
Nov 15, 2011·American Journal of Epidemiology·David G CoxUNKNOWN Breast and Prostate Cancer Cohort Consortium
Oct 9, 2014·International Journal of Clinical Pharmacology and Therapeutics·He Liang SunZhong Yun Wang

❮ Previous
Next ❯

Citations

Nov 30, 2016·Toxicologic Pathology·Michael Gochfeld
Oct 12, 2018·International Journal of Cancer. Journal International Du Cancer·Takiy BerrandouPascal Guénel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.